Shelton Capital Management

Source: SEC Form 13F · as of Mar 2026

Shelton Capital Management holds 40 biotech & pharma companies tracked by BioSniper, totaling $239.6M in value as of Mar 2026 (SEC Form 13F).

Companies held

40

Total value held

$239.6M

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Shelton Capital Management — Biotech 13F Holdings & Portfolio | BioSniper